- Home
- CRDL vs MAPS Comparison
CRDL vs MAPS Comparison
Compare CRDL & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- MAPS
- Stock Information
- Founded
- CRDL 2017
- MAPS 2008
- Country
- CRDL Canada
- MAPS United States
- Employees
- CRDL N/A
- MAPS N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- MAPS Computer Software: Prepackaged Software
- Sector
- CRDL Health Care
- MAPS Technology
- Exchange
- CRDL Nasdaq
- MAPS Nasdaq
- Market Cap
- CRDL 126.5M
- MAPS 126.2M
- IPO Year
- CRDL N/A
- MAPS N/A
- Fundamental
- Price
- CRDL $1.05
- MAPS $1.22
- Analyst Decision
- CRDL Strong Buy
- MAPS Strong Buy
- Analyst Count
- CRDL 2
- MAPS 1
- Target Price
- CRDL $9.00
- MAPS $2.61
- AVG Volume (30 Days)
- CRDL 1.2M
- MAPS 1.9M
- Earning Date
- CRDL 08-14-2025
- MAPS 08-07-2025
- Dividend Yield
- CRDL N/A
- MAPS N/A
- EPS Growth
- CRDL N/A
- MAPS N/A
- EPS
- CRDL N/A
- MAPS 0.09
- Revenue
- CRDL N/A
- MAPS $183,681,000.00
- Revenue This Year
- CRDL N/A
- MAPS N/A
- Revenue Next Year
- CRDL N/A
- MAPS $5.28
- P/E Ratio
- CRDL N/A
- MAPS $13.52
- Revenue Growth
- CRDL N/A
- MAPS 0.13
- 52 Week Low
- CRDL $0.77
- MAPS $0.70
- 52 Week High
- CRDL $2.63
- MAPS $1.65
- Technical
- Relative Strength Index (RSI)
- CRDL 39.49
- MAPS 59.36
- Support Level
- CRDL $1.12
- MAPS $1.07
- Resistance Level
- CRDL $1.14
- MAPS $1.25
- Average True Range (ATR)
- CRDL 0.07
- MAPS 0.08
- MACD
- CRDL -0.00
- MAPS -0.00
- Stochastic Oscillator
- CRDL 5.56
- MAPS 88.00
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises the B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on marketplace ads.